Doylestown Health is consistent with the COVID-19 recommendations of the Centers for Disease Control (CDC)

Doylestown Health supports continued proactive efforts to prevent an uncontrolled outbreak among our most vulnerable populations, including unvaccinated adults as well as children who are ineligible for vaccination at this time.

For more Doylestown Health COVID-19 information, visit our COVID-19 Update page.

Sarah R. Goodyear, MD

Sarah R Goodyear, MD

Hematology-Oncology, Medical Oncology, Oncology, Hematology

Clinical Services

Cancer

Education

Medical School: Temple University School of Medicine

Residency: Temple University Program

Fellowship: Fox Chase Cancer Center Program

Gender

Female

Language

English